Cargando…
Cell‐free DNA screening in twin pregnancies: A more accurate and reliable screening tool
OBJECTIVE: Outcome data from cell‐free DNA (cfDNA) screening in twin gestations are limited. This study adds an appreciable number of confirmed outcomes to the literature, and assesses performance of cfDNA screening in twins over a 4.5‐year period at one large clinical laboratory. METHOD: Prenatal c...
Autores principales: | Chibuk, Jason, Rafalko, Jill, Boomer, Theresa, McCullough, Ron, McLennan, Graham, Wyatt, Philip, Almasri, Eyad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540584/ https://www.ncbi.nlm.nih.gov/pubmed/32677048 http://dx.doi.org/10.1002/pd.5797 |
Ejemplares similares
-
A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory
por: Dyr, Brittany, et al.
Publicado: (2019) -
Impact of mosaicism ratio on positive predictive value of cfDNA screening
por: Rafalko, Jill M., et al.
Publicado: (2020) -
Application of mosaicism ratio to multifetal gestations
por: Rafalko, Jill, et al.
Publicado: (2021) -
Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants
por: Soster, Erica, et al.
Publicado: (2021) -
Positive cfDNA screening results for 22q11.2 deletion syndrome—Clinical and laboratory considerations
por: Soster, Erica, et al.
Publicado: (2023)